Stock HLTH CUE HEALTH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Cue Health Inc.

Equities

HLTH

US2297901009

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
0.131 USD -2.96% Intraday chart for Cue Health Inc. -2.96% -19.38%
04-24 Cue Health Inc. Announces Chief Financial Officer Changes, Effective as of May 13, 2024 CI
04-09 Cue Health Inc. Receives Response Letter from the U.S. Food and Drug Administration Regarding Its De Novo Request CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cue Health : Costs Associated with Exit/Disposal - Form 8-K
PU
Cue Health to Announce First Quarter Financial Results
BU
Cue Health Announces Strategic Actions to Position Company for Next Stage
BU
Cue Health Reports Fourth Quarter 2023 Financial Results
BU
Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results
BU
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
BU
Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
BU
Cue Health Reports Third Quarter 2023 Financial Results
BU
Cue Health to Announce Third Quarter 2023 Financial Results
BU
Concerned Stockholders of Cue Health Send Letter to Board
BU
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health's Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
AQ
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
BU
Cue Health Adopts Limited-Duration Shareholder Rights Plan
BU
Cue Health to Present at Upcoming Investor Conferences
BU
Cue Health Reports Second Quarter 2023 Financial Results
BU
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
BU
Cue Health to Announce Second Quarter 2023 Financial Results
BU
Cue Health Achieves Groundbreaking Milestone with FDA, First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
AQ
FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process
AQ
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HLTH Stock
  4. News Cue Health Inc.
  5. Press Releases